Ritter Pharmaceuticals
Latest round
- Series C
Last raised
- Dec 2014
Total raised
- $12M
Investors
- 1
About Ritter Pharmaceuticals
Founded in 2004 and based in California, US, Ritter Pharmaceuticals, Inc. operates as a manufacturer of therapeutic products that treat gastrointestinal diseases. The company has developed RP-G28 which is a FDA-approved treatment for lactose intolerance. The company also researches and develops treatments for other gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.
Who invested in Ritter Pharmaceuticals
1 investor across 5 rounds
See all investors in Ritter Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ritter Pharmaceuticals
Who invested in Ritter Pharmaceuticals?
Ritter Pharmaceuticals has 1 investor on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ritter Pharmaceuticals raised?
Ritter Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Ritter Pharmaceuticals last raise money?
Ritter Pharmaceuticals's most recent round on record is a Series C, in Dec 2014.
What does Ritter Pharmaceuticals do?
Founded in 2004 and based in California, US, Ritter Pharmaceuticals, Inc.
Where is Ritter Pharmaceuticals headquartered?
Ritter Pharmaceuticals is headquartered in Los Angeles, US.
Which VCs invest in companies like Ritter Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ritter Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Ritter Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.